Connect Biopharma Holdings Ltd (CNTB) Institutional Ownership Changes & 13F Activity
Connect Biopharma Holdings Ltd (CNTB). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ikarian Capital, Llc, Silverarc Capital Management, Llc, Millennium Management Llc, 683 Capital Management, Llc, and Marshall Wace, Llp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, Llc | Buy | +54,254 | +17.5% | 364,254 | $866.92K | Q2 2026 | Aug 17, 2026 |
| Ikarian Capital, Llc | Sell | -849,952 | -15.8% | 4,538,534 | $10.80M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -430,893 | -90.8% | 43,708 | $104.03K | Q2 2026 | Aug 14, 2026 |
| 683 Capital Management, Llc | Buy | +385,000 | +42.8% | 1,285,000 | $3.06M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Sell | -260,850 | -21.1% | 973,732 | $2.32M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -176,660 | -63.4% | 102,148 | $243.11K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +151,916 | +320.1% | 199,381 | $474.53K | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Sell | -42,400 | -5.7% | 700,000 | $1.67M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +36,760 | — | 36,760 | $87.49K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +25,247 | +161.1% | 40,920 | $97.39K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +13,240 | — | 13,240 | $31.51K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +12,469 | — | 12,469 | $30.00K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -12,469 | -30.3% | 28,659 | $68.21K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +6,904 | — | 6,904 | $16.43K | Q2 2026 | Aug 14, 2026 |
| Diadema Partners Lp | Sell | -3,705 | -1.8% | 196,985 | $468.82K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +2,879 | — | 2,879 | $6.85K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +2,415 | — | 2,415 | $5.75K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +540 | +1.3% | 40,940 | $97.00K | Q2 2026 | Aug 14, 2026 |
| Silverarc Capital Management, Llc | Buy | +545,000 | — | 545,000 | $1.30M | Q2 2026 | Aug 13, 2026 |
| Marshall Wace, Llp | Buy | +269,629 | +408.4% | 335,642 | $798.83K | Q2 2026 | Aug 13, 2026 |
| Vanguard Portfolio Management Llc | Buy | +102,755 | — | 102,755 | $244.56K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +82,862 | — | 82,862 | $197.21K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +66,418 | +201266.7% | 66,451 | $158.15K | Q2 2026 | Aug 13, 2026 |
| Renaissance Technologies LLC | Sell | -33,400 | -27.7% | 87,300 | $207.77K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +11,314 | — | 11,314 | $26.93K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +5,049 | +140.6% | 8,639 | $20.56K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Buy | +2,290 | — | 2,290 | $5.45K | Q2 2026 | Aug 13, 2026 |
| Huntington National Bank | Buy | +996 | — | 996 | $2.37K | Q2 2026 | Aug 13, 2026 |
| Fmr Llc | Buy | +314 | — | 314 | $747.00 | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Buy | +225,325 | +701.3% | 257,454 | $612.74K | Q2 2026 | Aug 12, 2026 |
Frequently asked questions about CNTB activity
Which institutional owners are buying CNTB?
Institutional owners buying CNTB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CNTB activity?
"Buy" means an investor increased their reported position in CNTB compared to the prior reporting period. This reflects growing exposure to Connect Biopharma Holdings Ltd (CNTB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CNTB increasing?
Institutional interest in CNTB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.